香港股市 將在 5 小時 44 分鐘 開市

Coloplast A/S (CLPBF)

Other OTC - Other OTC 延遲價格。貨幣為 USD。
加入追蹤清單
119.500.00 (0.00%)
市場開市。 截至 12:43PM EDT。

Coloplast A/S

Holtedam 1-3
Humlebæk 3050
Denmark
45 49 11 11 11
https://www.coloplast.com

版塊Healthcare
行業Medical Instruments & Supplies
全職員工15,751

高階主管

名稱頭銜支付行使價出生年份
Mr. Kristian VillumsenPresident & CEO2.5M1970
Mr. Anders Lonning-SkovgaardExecutive VP & CFO1.29M1972
Mr. Allan RasmussenExecutive Vice President of Global Operations1.13M1967
Mr. Nicolai Buhl AndersenExecutive Vice President of Innovation1.09M1969
Mr. Paul MarcunExecutive Vice President of Growth1.3M1967
Mr. Thomas BarfodSenior Controller & Employees Representative Director64.35k1970
Ellen BjurgertVice President of Investor Relations
Dennis KaysenDirector of Corporate Communications
Dorthe RonnauSenior Vice President of People & Culture1966
Mr. Alain MorvanSenior Vice President of Sales Europe
截止 2023年12月31日為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. The company was founded in 1954 and is headquartered in Humlebæk, Denmark.

公司管治

截至 2024年5月1日 止,Coloplast A/S 的 ISS 管治質素評分為 3。 Pillar 分數正在審核中:1;董事會:5;股東權利:9;現金賠償:2。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。